Crinetics Pharmaceuticals, Inc. Made Headway
Mon, Sep 11, 2023 at 07:24 PM
Crinetics Pharmaceuticals, Inc. (CRNX:NASDAQ) soared at $26.08, representing a gain of 63.3%. On Mon, Sep 11, 2023, CRNX:NASDAQ touched a New 2-Week High of $26.08. The stock got featured on our News Catalysts scanner on Mon, Sep 11, 2023 at 04:39 PM in the 'PUBLIC OFFERING' category. From Mon, Aug 28, 2023, the stock recorded 33.33% Up Days and 30.00% Green Days
About Crinetics Pharmaceuticals, Inc. (CRNX:NASDAQ)
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
Top 10 Gainers:
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 218.18%
- Viveve Medical, Inc. (VIVE:NASDAQ), 88.24%
- Canopy Growth Corporation (CGC:NASDAQ), 81.37%
- Aurora Cannabis Inc. (ACB:NASDAQ), 72.17%
- Crinetics Pharmaceuticals, Inc. (CRNX:NASDAQ), 63.31%
- Akanda Corp. (AKAN:NASDAQ), 41.8%
- Eightco Holdings Inc Com (New) (OCTO:NASDAQ), 35.69%
- noco-noco Inc. (NCNC:NASDAQ), 33.91%
- Yoshiharu Global Co. (YOSH:NASDAQ), 31.23%
- MarketWise Inc. (MKTW:NASDAQ), 31.16%